Improve Medical Instruments Co., Ltd. (SHE:300030)
China flag China · Delayed Price · Currency is CNY
6.42
+0.07 (1.10%)
Aug 3, 2026, 12:34 PM CST

SHE:300030 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
28.414.53-117.9-63.2-198.318.57
Depreciation & Amortization
33.9633.9639.8545.1346.7553.31
Other Amortization
1.981.982.033.582.672.63
Loss (Gain) From Sale of Assets
-2.09-2.09-0.9-6.45-0.44-0.02
Asset Writedown & Restructuring Costs
22.622.623.338.9990.081.39
Loss (Gain) From Sale of Investments
-10.31-10.3163.56-7.4453.1-19.34
Provision & Write-off of Bad Debts
-5.28-5.2823.96-3.089.17.75
Other Operating Activities
18.4617.2534.5247.9253.4744.18
Change in Accounts Receivable
141.92141.9219.652.76-12.59109.82
Change in Inventory
9.129.12-0.09-19.77-16.14-15.78
Change in Accounts Payable
-117.32-117.32-1.926.9738.21-32.99
Operating Cash Flow
124.97109.981.8479.942.48171.74
Operating Cash Flow Growth
57.33%34.29%2.42%88.11%-75.27%21.56%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-25.21-24.12-51.28-43.7-58.04-71.05
Sale of Property, Plant & Equipment
1.231.5837.513.60.060.13
Divestitures
----26.62.71
Investment in Securities
1128.35-20-13.255.79
Other Investing Activities
8.9126.52-1.0821.59-22.62
Investing Cash Flow
-14.084.9813.5-38.5-44.64-39.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-231.4354.73393.58381.99272.62
Long-Term Debt Repaid
--425.99-405.57-425.18-467.2-250.39
Net Debt Issued (Repaid)
-114.68-194.59-50.84-31.6-85.2122.24
Issuance of Common Stock
--0.03--9.91
Common Dividends Paid
-4.55-5.5-11.97-15.94-37.67-31.14
Other Financing Activities
-2.45-3.232.14-2.562.05-3.57
Financing Cash Flow
-121.68-203.32-60.63-50.09-120.83-2.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.470.321.230.610.98-0.88
Net Cash Flow
-11.26-88.1335.94-8.08-122.01128.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
99.7685.7730.5536.2-15.56100.69
Free Cash Flow Growth
207.55%180.72%-15.60%--19.22%
Free Cash Flow Margin
21.41%17.64%5.26%5.62%-2.19%12.59%
Free Cash Flow Per Share
0.330.290.100.12-0.050.33
Levered Free Cash Flow
89.4881.5753.0111.4-9.7842.7
Unlevered Free Cash Flow
92.1984.7859.9421.762.5358.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
24.2223.7626.2122.4830.0347.81
Change in Working Capital
37.2637.2613.454.48-13.9463.26